PPARγ antagonists induce aromatase transcription in adipose tissue cultures
- 1The National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark; The National Research Centre for the Working Environment, Copenhagen Ø, Denmark.
- 2REPIN and Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
- 3The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen N, Denmark.
- 4The National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark.
- 5Department of Medicine, Weill Cornell Medicine, New York, NY, USA; Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
- 0The National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark; The National Research Centre for the Working Environment, Copenhagen Ø, Denmark.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Environmental chemicals acting as PPARγ antagonists can promote breast cancer by increasing aromatase expression in adipose tissue, affecting both adipogenesis and directly upregulating aromatase.
Area Of Science
- Endocrinology
- Molecular Biology
- Environmental Health
Background
- Aromatase is crucial for estrogen biosynthesis and a risk factor for hormone receptor-positive breast cancer.
- Estrogen synthesized in adipose tissue fuels breast cancer growth in postmenopausal women.
- Peroxisome proliferator-activated receptor gamma (PPARγ) activation in adipose stromal cells (ASCs) reduces aromatase and promotes adipocyte differentiation.
Purpose Of The Study
- To investigate if PPARγ antagonists promote breast cancer by stimulating aromatase expression in human adipose tissue.
- To elucidate the mechanisms by which PPARγ antagonists affect adipogenesis and aromatase expression.
- To assess the impact of environmental PPARγ antagonists on estrogen biosynthesis.
Main Methods
- Utilized primary human adipose tissue cells and explants, alongside cell lines (A41hWAT, C3H10T1/2, H295R).
- Assessed effects on adipogenesis, aromatase expression, and estrogen biosynthesis.
- Employed Nuclear Magnetic Resonance (NMR) spectroscopy to confirm molecular interactions.
Main Results
- PPARγ antagonists inhibited adipocyte differentiation, preventing aromatase downregulation.
- DEHPA, a potent antagonist, directly interacted with PPARγ, blocking agonist binding.
- ASCs exposed to antagonists showed upregulated aromatase, particularly in differentiated cells and human adipose tissue explants.
- Overexpression of PPARG reduced aromatase expression.
Conclusions
- Environmental PPARγ antagonists can promote breast cancer via adipose tissue aromatase upregulation.
- Two mechanisms are involved: indirect inhibition of adipogenesis and acute direct upregulation of aromatase.
- Findings highlight the role of environmental chemicals in endocrine disruption and breast cancer progression.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:58
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:31
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
...

